Sign in
CompletedNo phase

Evaluation of Eye Health Benefits of Black Tomato Extract

Key facts

Who runs it
TCI Co., Ltd.
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
56 people enrolled
Started
1 Apr 2024
Ended
30 Apr 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Black tomato extract powder
  • Placebo powder
Record updated
13 June 2025

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age greater than 20 and capable of providing informed consent
  • Daily usage of 3C (computer, communication, and consumer electronics) for more than 6 hours (OSDI screening - those experiencing dryness and fatigue in the eyes)
  • BMI between 22 and 35
  • High myopia population (-5.00 to -9.00D)

Who cannot take part

  • Long-term use of medications affecting the anterior surface of the eye
  • History of any eye surgery (e.g., strabismus surgery, refractive surgery)
  • Presence of systemic diseases affecting the anterior surface of the eye

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Verification of the efficacy of black tomato extract for eye health.

The 2 groups in the trial

  • Placebo powderPlacebo, for comparison

    Dietary Supplement: Placebo powder

  • Black tomato extract powderTreatment being tested

    Dietary Supplement: Black tomato extract powder

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 June 2025